Zaid Al-Qurayshi1, Gregory W Randolph2, Sudesh Srivastav3, Emad Kandil1. 1. Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana. 2. Division of Thyroid and Parathyroid Endocrine Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. 3. Department of Biostatistics and Bioinformatics, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Surgeon experience has been recognized in several clinical fields as a significant element of superior management outcomes. In this study, we seek to assess the association between surgeon volume and patients' community health status with the outcomes of thyroid and parathyroid surgery indicated for primary malignancies. STUDY DESIGN: A cross-sectional study utilizing the State Inpatient Databases, 2010-2011, for Florida, New York, and Washington was merged with the County Health Rankings database. METHODS: International Classification of Diseases, Ninth Revision codes were used to identify adult (≥18 years) patients who underwent thyroidectomy or parathyroidectomy indicated for primary malignancies. RESULTS: A total of 6,347 records were included. Compared to high-volume surgeons, patients treated by low-volume surgeons were more likely to develop postoperative complications in the 1-month period after the operation (odds ratio: 4.34, 95% confidence interval: 3.31-5.70, P < .001). Furthermore, both low- and intermediate-volume surgeons were associated with a longer hospital stay (>2 days) and a higher risk of admission to the intensive care unit (P < .01 each). Cost of health services was significantly in the highest quartile (>$10,254.66) for patients treated by low-volume surgeons (P < .001). Patients who lived in communities of poor health measures had a higher risk of postoperative complications (16.3% vs. 11.8%, P = .030) independent of the clinical presentation and management type. Patients living in high health-risk communities and those of black and Hispanic backgrounds were more likely to be treated by low-volume surgeons (P < .001 each). CONCLUSIONS: The surgeon's volume and the patient's living conditions are crucial and independent factors in multiple aspects of endocrine cancer management. LEVEL OF EVIDENCE: 4 Laryngoscope, 126:775-781, 2016.
OBJECTIVES/HYPOTHESIS: Surgeon experience has been recognized in several clinical fields as a significant element of superior management outcomes. In this study, we seek to assess the association between surgeon volume and patients' community health status with the outcomes of thyroid and parathyroid surgery indicated for primary malignancies. STUDY DESIGN: A cross-sectional study utilizing the State Inpatient Databases, 2010-2011, for Florida, New York, and Washington was merged with the County Health Rankings database. METHODS: International Classification of Diseases, Ninth Revision codes were used to identify adult (≥18 years) patients who underwent thyroidectomy or parathyroidectomy indicated for primary malignancies. RESULTS: A total of 6,347 records were included. Compared to high-volume surgeons, patients treated by low-volume surgeons were more likely to develop postoperative complications in the 1-month period after the operation (odds ratio: 4.34, 95% confidence interval: 3.31-5.70, P < .001). Furthermore, both low- and intermediate-volume surgeons were associated with a longer hospital stay (>2 days) and a higher risk of admission to the intensive care unit (P < .01 each). Cost of health services was significantly in the highest quartile (>$10,254.66) for patients treated by low-volume surgeons (P < .001). Patients who lived in communities of poor health measures had a higher risk of postoperative complications (16.3% vs. 11.8%, P = .030) independent of the clinical presentation and management type. Patients living in high health-risk communities and those of black and Hispanic backgrounds were more likely to be treated by low-volume surgeons (P < .001 each). CONCLUSIONS: The surgeon's volume and the patient's living conditions are crucial and independent factors in multiple aspects of endocrine cancer management. LEVEL OF EVIDENCE: 4 Laryngoscope, 126:775-781, 2016.
Authors: Karishma Jassal; Nandhini Ravintharan; Swetha Prabhakaran; Simon Grodski; Jonathan W Serpell; James C Lee Journal: ANZ J Surg Date: 2022-04-12 Impact factor: 2.025
Authors: Sanghee Hong; Ruta Brazauskas; Kyle M Hebert; Siddhartha Ganguly; Hisham Abdel-Azim; Miguel Angel Diaz; Sara Beattie; Stefan O Ciurea; David Szwajcer; Sherif M Badawy; Alois A Gratwohl; Charles LeMaistre; Mahmoud D S M Aljurf; Richard F Olsson; Neel S Bhatt; Nosha Farhadfar; Jean A Yared; Ayami Yoshimi; Sachiko Seo; Usama Gergis; Amer M Beitinjaneh; Akshay Sharma; Hillard Lazarus; Jason Law; Matthew Ulrickson; Hasan Hashem; Hélène Schoemans; Jan Cerny; David Rizzieri; Bipin N Savani; Rammurti T Kamble; Bronwen E Shaw; Nandita Khera; William A Wood; Shahrukh Hashmi; Theresa Hahn; Stephanie J Lee; J Douglas Rizzo; Navneet S Majhail; Wael Saber Journal: Cancer Date: 2020-10-21 Impact factor: 6.860